Global Animal Stem Cell Therapy Market Insights and Forecast to 2026 by Top Companies

In this report,global Animal Stem Cell Therapy Market will reach 36072 K USD by the end of 2022 with a CAGR of 21.70%

The global Animal Stem Cell Therapy market is valued at 13514 K USD in 2017 and will reach 36072 K USD by the end of 2022, growing at a CAGR of 21.70% during 2017-2022.

Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.

The classification of Animal Stem Cell Therapy includes dogs, horses and others, and the proportion of dogs in 2016 is about 51%, and the proportion is in increasing trend from 2012 to 2016.

Animal Stem Cell Therapy is widely used in veterinary hospitals and research organizations. The most proportion of Animal Stem Cell Therapy is used in veterinary hospitals, and the revenue in 2016 is 8.09 M USD.

XYZ research center data shows that North America is the biggest contributor to the Animal Stem Cell Therapy revenue market, accounted for 55.56% of the total global market with a revenue of 7508 K USD in 2017, followed by Japan, 20.57% with a revenue of 2780 K USD.

VETSTEM BIOPHARMA is the largest company in the global Animal Stem Cell Therapy market, accounted for 22.81% of the revenue market share in 2017, followed by MediVet Biologic and J-ARM, accounted for 17.15% and 14.41% of the revenue market share in 2017. These manufacturers are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Animal Stem Cell Therapy in these regions, from 2014 to 2026 (forecast), covering
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Animal Stem Cell Therapy market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
VETSTEM BIOPHARMA
MediVet Biologic
J-ARM
Celavet
Magellan Stem Cells
U.S. Stem Cell
Cells Power Japan
ANIMAL CELL THERAPIES
Animal Care Stem
Cell Therapy Sciences
VetCell Therapeutics
Animacel
Aratana Therapeutics
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Dogs
Horses
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Animal Stem Cell Therapy for each application, including
Veterinary Hospitals
Research Organizations

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Animal Stem Cell Therapy Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Animal Stem Cell Therapy Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Dogs Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Horses Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Others Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Animal Stem Cell Therapy Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Animal Stem Cell Therapy Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Animal Stem Cell Therapy Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Animal Stem Cell Therapy Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Animal Stem Cell Therapy Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Animal Stem Cell Therapy Market Assessment by Type
8.1 Asia Pacific Animal Stem Cell Therapy Market Assessment by Application (Consumption and Market Share)
8.2 North America Animal Stem Cell Therapy Market Assessment by Application (Consumption and Market Share)
8.3 Europe Animal Stem Cell Therapy Market Assessment by Application (Consumption and Market Share)
8.4 South America Animal Stem Cell Therapy Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Animal Stem Cell Therapy Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 VETSTEM BIOPHARMA
9.1.1 VETSTEM BIOPHARMA Profiles
9.1.2 VETSTEM BIOPHARMA Product Portfolio
9.1.3 VETSTEM BIOPHARMA Animal Stem Cell Therapy Business Performance
9.1.4 VETSTEM BIOPHARMA Animal Stem Cell Therapy Business Development and Market Status
9.2 MediVet Biologic
9.2.1 MediVet Biologic Profiles
9.2.2 MediVet Biologic Product Portfolio
9.2.3 MediVet Biologic Animal Stem Cell Therapy Business Performance
9.2.4 MediVet Biologic Animal Stem Cell Therapy Business Development and Market Status
9.3 J-ARM
9.3.1 J-ARM Profiles
9.3.2 J-ARM Product Portfolio
9.3.3 J-ARM Animal Stem Cell Therapy Business Performance
9.3.4 J-ARM Animal Stem Cell Therapy Business Development and Market Status
9.4 Celavet
9.4.1 Celavet Profiles
9.4.2 Celavet Product Portfolio
9.4.3 Celavet Animal Stem Cell Therapy Business Performance
9.4.4 Celavet Animal Stem Cell Therapy Business Development and Market Status
9.5 Magellan Stem Cells
9.5.1 Magellan Stem Cells Profiles
9.5.2 Magellan Stem Cells Product Portfolio
9.5.3 Magellan Stem Cells Animal Stem Cell Therapy Business Performance
9.5.4 Magellan Stem Cells Animal Stem Cell Therapy Business Development and Market Status
9.6 U.S. Stem Cell
9.6.1 U.S. Stem Cell Profiles
9.6.2 U.S. Stem Cell Product Portfolio
9.6.3 U.S. Stem Cell Animal Stem Cell Therapy Business Performance
9.6.4 U.S. Stem Cell Animal Stem Cell Therapy Business Development and Market Status
9.7 Cells Power Japan
9.7.1 Cells Power Japan Profiles
9.7.2 Cells Power Japan Product Portfolio
9.7.3 Cells Power Japan Animal Stem Cell Therapy Business Performance
9.7.4 Cells Power Japan Animal Stem Cell Therapy Business Development and Market Status
9.8 ANIMAL CELL THERAPIES
9.8.1 ANIMAL CELL THERAPIES Profiles
9.8.2 ANIMAL CELL THERAPIES Product Portfolio
9.8.3 ANIMAL CELL THERAPIES Animal Stem Cell Therapy Business Performance
9.8.4 ANIMAL CELL THERAPIES Animal Stem Cell Therapy Business Development and Market Status
9.9 Animal Care Stem
9.9.1 Animal Care Stem Profiles
9.9.2 Animal Care Stem Product Portfolio
9.9.3 Animal Care Stem Animal Stem Cell Therapy Business Performance
9.9.4 Animal Care Stem Animal Stem Cell Therapy Business Development and Market Status
9.10 Cell Therapy Sciences
9.10.1 Cell Therapy Sciences Profiles
9.10.2 Cell Therapy Sciences Product Portfolio
9.10.3 Cell Therapy Sciences Animal Stem Cell Therapy Business Performance
9.10.4 Cell Therapy Sciences Animal Stem Cell Therapy Business Development and Market Status
9.11 VetCell Therapeutics
9.12 Animacel
9.13 Aratana Therapeutics
10 World Animal Stem Cell Therapy Market Assessment by Players
10.1 Global Animal Stem Cell Therapy Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Animal Stem Cell Therapy Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Animal Stem Cell Therapy Price (USD/Unit) of Players 2014-2020
10.4 Global Animal Stem Cell Therapy Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Animal Stem Cell Therapy Sales Assessment of Players 2014-2020
11.1.2 North America Animal Stem Cell Therapy Revenue Assessment of Players 2014-2020
11.1.3 North America Animal Stem Cell Therapy Price Assessment of Players 2014-2020
11.1.4 North America Animal Stem Cell Therapy Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Animal Stem Cell Therapy Sales Assessment of Players 2014-2020
11.2.2 Europe Animal Stem Cell Therapy Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Animal Stem Cell Therapy Price Assessment of Players 2014-2020
11.2.4 Europe Animal Stem Cell Therapy Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Animal Stem Cell Therapy Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Animal Stem Cell Therapy Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Animal Stem Cell Therapy Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Animal Stem Cell Therapy Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Animal Stem Cell Therapy Sales Assessment of Players 2014-2020
11.4.2 South America Animal Stem Cell Therapy Revenue Assessment of Players 2014-2020
11.4.3 South America Animal Stem Cell Therapy Price Assessment of Players 2014-2020
11.4.4 South America Animal Stem Cell Therapy Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Animal Stem Cell Therapy Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Animal Stem Cell Therapy Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Animal Stem Cell Therapy Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Animal Stem Cell Therapy Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Animal Stem Cell Therapy Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Animal Stem Cell Therapy Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Animal Stem Cell Therapy Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Animal Stem Cell Therapy Sales by Countries/Regions 2014-2020
12.2.2 North America Animal Stem Cell Therapy Revenue by Countries/Regions 2014-2020
12.2.3 North America Animal Stem Cell Therapy Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Animal Stem Cell Therapy Sales by Countries/Regions 2014-2020
12.3.2 Europe Animal Stem Cell Therapy Revenue by Countries/Regions 2014-2020
12.3.3 Europe Animal Stem Cell Therapy Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Animal Stem Cell Therapy Sales by Countries/Regions 2014-2020
12.4.2 South America Animal Stem Cell Therapy Revenue by Countries/Regions 2014-2020
12.4.3 South America Animal Stem Cell Therapy Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Animal Stem Cell Therapy Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Animal Stem Cell Therapy Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Animal Stem Cell Therapy Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Animal Stem Cell Therapy Sales & Revenue Forecast 2021-2026
14.1 World Animal Stem Cell Therapy Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Animal Stem Cell TherapySales and Market Share by Regions
14.1.2 World Animal Stem Cell TherapyRevenue and Market Share by Regions
15 Asia Animal Stem Cell Therapy Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Dogs
15.1.2 Horses
15.1.3 Others
15.2 Consumption Forecast by Application, 2021-2026
16 North America Animal Stem Cell Therapy Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Dogs
16.1.2 Horses
16.1.3 Others
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Animal Stem Cell Therapy Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Dogs
17.1.2 Horses
17.1.3 Others
17.2 Consumption Forecast by Application, 2021-2026
18 South America Animal Stem Cell Therapy Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Dogs
18.1.2 Horses
18.1.3 Others
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Animal Stem Cell Therapy Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Dogs
19.1.2 Horses
19.1.3 Others
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Animal Stem Cell Therapy Price (USD/Unit) Trend 2021-2026
20.2 Global Animal Stem Cell Therapy Gross Profit Trend 2021-2026
21 Conclusion